Related Experiment Video
Updated: Aug 2, 2026
10:22
Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
Published on: September 16, 2011
34.2K
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF
Summary
This clinical practice guideline provides evidence-based recommendations for managing dyslipidemia, focusing on updated low-density lipoprotein cholesterol (LDL-C) goals and risk stratification. It aims to reduce cardiovascular risks for diverse patient populations.
Area of Science:
- Endocrinology and Metabolism
- Cardiovascular Disease Prevention
- Clinical Practice Guidelines
Background:
- Development mandated by the American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE).
- Adheres to established AACE/ACE protocols for standardized clinical practice guideline (CPG) production.
- Extensive glossary of abbreviations provided for clarity in scientific communication.
Purpose of the Study:
- To provide endocrinologists and healthcare professionals with a practical tool for managing dyslipidemia.
- To guide screening, risk assessment, and treatment decisions for various lipid disorders.
- To reduce the risks and consequences associated with dyslipidemia.
Main Methods:
- Recommendations derived from diligent reviews of clinical evidence.
- Transparent incorporation of subjective factors in accordance with AACE/ACE guidelines.
- Evidence base includes 695 citations categorized by evidence level (EL 1-4).
Main Results:
- The Executive Summary includes 87 recommendations: 45 Grade A (51.7%), 18 Grade B (20.7%), 15 Grade C (17.2%), and 9 Grade D (10.3%).
- Detailed, evidence-based recommendations support nuanced clinical decision-making.
- Evidence base comprises 203 strong (EL 1), 137 intermediate (EL 2), 119 weak (EL 3), and 236 no clinical evidence (EL 4) citations.
Conclusions:
- Emphasizes treating low-density lipoprotein cholesterol (LDL-C) to potentially lower goals than previously endorsed.
- Supports using coronary artery calcium (CAC) scores and inflammatory markers for risk stratification.
- Provides special considerations for individuals with diabetes, familial hypercholesterolemia, women, and youth, including cost-effectiveness data.
More Related Videos
07:52Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
Published on: September 10, 2018
9.3K
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
9.1K
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:18Lipids: Dietary Sources and Requirements
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:23Atherosclerosis IV: Nursing Management
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...